Literature DB >> 26588930

Protoporphyrin IX: the Good, the Bad, and the Ugly.

Madhav Sachar1, Karl E Anderson1, Xiaochao Ma2.   

Abstract

Protoporphyrin IX (PPIX) is ubiquitously present in all living cells in small amounts as a precursor of heme. PPIX has some biologic functions of its own, and PPIX-based strategies have been used for cancer diagnosis and treatment (the good). PPIX serves as the substrate for ferrochelatase, the final enzyme in heme biosynthesis, and its homeostasis is tightly regulated during heme synthesis. Accumulation of PPIX in human porphyrias can cause skin photosensitivity, biliary stones, hepatobiliary damage, and even liver failure (the bad and the ugly). In this work, we review the mechanisms that are associated with the broad aspects of PPIX. Because PPIX is a hydrophobic molecule, its disposition is by hepatic rather than renal excretion. Large amounts of PPIX are toxic to the liver and can cause cholestatic liver injury. Application of PPIX in cancer diagnosis and treatment is based on its photodynamic effects.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26588930      PMCID: PMC4727154          DOI: 10.1124/jpet.115.228130

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  166 in total

1.  Heme proteins--diversity in structural characteristics, function, and folding.

Authors:  Lorna J Smith; Abdullah Kahraman; Janet M Thornton
Journal:  Proteins       Date:  2010-08-01

Review 2.  Erythropoietic protoporphyria: clinical aspects with emphasis on the skin.

Authors:  H Baart de la Faille; J C Bijlmer-Iest; J van Hattum; J Koningsberger; L H Rademakers; H van Weelden
Journal:  Curr Probl Dermatol       Date:  1991

Review 3.  Erythropoietic protoporphyria. An overview with emphasis on the liver.

Authors:  L Meerman
Journal:  Scand J Gastroenterol Suppl       Date:  2000

Review 4.  Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.

Authors:  T J Sadlon; T Dell'Oso; K H Surinya; B K May
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

5.  Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses.

Authors:  P Collins; J Ferguson
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

6.  Acute intermittent porphyria: effect of diet and griseofulvin.

Authors:  B F Felsher; A G Redeker
Journal:  Medicine (Baltimore)       Date:  1967-03       Impact factor: 1.889

7.  Afamelanotide for Erythropoietic Protoporphyria.

Authors:  Janneke G Langendonk; Manisha Balwani; Karl E Anderson; Herbert L Bonkovsky; Alexander V Anstey; D Montgomery Bissell; Joseph Bloomer; Chris Edwards; Norbert J Neumann; Charles Parker; John D Phillips; Henry W Lim; Iltefat Hamzavi; Jean-Charles Deybach; Raili Kauppinen; Lesley E Rhodes; Jorge Frank; Gillian M Murphy; Francois P J Karstens; Eric J G Sijbrands; Felix W M de Rooij; Mark Lebwohl; Hetanshi Naik; Colin R Goding; J H Paul Wilson; Robert J Desnick
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

8.  A double-blind study of cysteine photoprotection in erythropoietic protoporphyria.

Authors:  M M Mathews-Roth; B Rosner; K Benfell; J E Roberts
Journal:  Photodermatol Photoimmunol Photomed       Date:  1994-12       Impact factor: 3.135

9.  Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.

Authors:  Jianyu Zheng; Ying Shan; Richard W Lambrecht; Susan E Donohue; Herbert L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2008-08-22       Impact factor: 3.396

10.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  48 in total

1.  Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.

Authors:  Madhav Sachar; Feng Li; Ke Liu; Pengcheng Wang; Jie Lu; Xiaochao Ma
Journal:  Chem Res Toxicol       Date:  2016-08-02       Impact factor: 3.739

2.  Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.

Authors:  John Phillips; Collin Farrell; Yongming Wang; Ashwani K Singal; Karl Anderson; Manisha Balwani; Montgomery Bissell; Herbert Bonkovsky; Toni Seay; Barry Paw; Robert Desnick; Joseph Bloomer
Journal:  Mol Genet Metab       Date:  2018-10-22       Impact factor: 4.797

3.  Nrf2 Ameliorates DDC-Induced Sclerosing Cholangitis and Biliary Fibrosis and Improves the Regenerative Capacity of the Liver.

Authors:  Athanassios Fragoulis; Julia Schenkel; Miriam Herzog; Tim Schellenberg; Holger Jahr; Thomas Pufe; Christian Trautwein; Thomas W Kensler; Konrad L Streetz; Christoph Jan Wruck
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 4.  Membrane transporters in traumatic brain injury: Pathological, pharmacotherapeutic, and developmental implications.

Authors:  Fanuel T Hagos; Solomon M Adams; Samuel M Poloyac; Patrick M Kochanek; Christopher M Horvat; Robert S B Clark; Philip E Empey
Journal:  Exp Neurol       Date:  2019-02-21       Impact factor: 5.330

5.  Ultracompact fluorescence smartphone attachment using built-in optics for protoporphyrin-IX quantification in skin.

Authors:  Brady Hunt; Samuel S Streeter; Alberto J Ruiz; M Shane Chapman; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2021-10-19       Impact factor: 3.732

6.  Mitochondrial-nuclear heme trafficking in budding yeast is regulated by GTPases that control mitochondrial dynamics and ER contact sites.

Authors:  Osiris Martinez-Guzman; Mathilda M Willoughby; Arushi Saini; Jonathan V Dietz; Iryna Bohovych; Amy E Medlock; Oleh Khalimonchuk; Amit R Reddi
Journal:  J Cell Sci       Date:  2020-05-20       Impact factor: 5.285

7.  Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury.

Authors:  Yifan Bao; Xiaochao Ma; Theodore P Rasmussen; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2018-03-15

8.  Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.

Authors:  Heidi M Schmidt; Katherine C Wood; Sara E Lewis; Scott A Hahn; Xena M Williams; Brenda McMahon; Jeffrey J Baust; Shuai Yuan; Timothy N Bachman; Yekai Wang; Joo-Yeun Oh; Samit Ghosh; Solomon F Ofori-Acquah; Jeffrey D Lebensburger; Rakesh P Patel; Jianhai Du; Dario A Vitturi; Eric E Kelley; Adam C Straub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

9.  Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Authors:  Jacqueline Bezençon; Chitra Saran; Janine Hussner; James J Beaudoin; Yueping Zhang; Hong Shen; John K Fallon; Philip C Smith; Henriette E Meyer Zu Schwabedissen; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2020-10-13       Impact factor: 3.534

10.  Association between protoporphyrin IX and sarcopenia: a cross sectional study.

Authors:  Chia-Chun Kao; Zhe-Yu Yang; Wei-Liang Chen
Journal:  BMC Geriatr       Date:  2021-06-26       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.